Relafen 750, the advanced preparation of naproxen, offers the intriguing case from a biochemical pharmacy view. This mode of action, mainly involving blocking of cyclooxygenase enzymes and COX-1 and COX-2 – results to a decrease in prostaglandin production. Within a biochemical lens, the drug's potency is strongly associated to this ability to mo